Literature DB >> 33225387

Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression.

Yong-Hyun Ko1, Seon-Kyung Kim1, Seok-Yong Lee1, Choon-Gon Jang2.   

Abstract

Emotional disorders such as anxiety and depression are widespread psychological diseases that affect up to 20% of the world's population. There are many approaches to the discovery of novel agents for the treatment of depressive- and anxiety-like symptoms. However, the efficacy of existing drugs for emotional disorders is only exerted after a few weeks of treatment and have serious side effects. Due to this, new strategies to find suitable and safe options are being sought by many researchers. Among them, a lot of interest has been attracted by plant-derived natural compounds due to their wide range of beneficial effects for new agent development. Flavonoids are natural polyphenol-like compounds found commonly in plants, fruits, vegetables, and medicinal herbs. A diverse range of flavonoids have been studied to investigate their potential therapeutic activities for the treatment of brain-associated disorders, including anxiety and depression. The main aim of this review is to understand the associations between the various flavonoids and the emotional disorders and discuss the therapeutic effects of these natural compounds that were demonstrated during the conduction of recent studies. The current work shows advances in the latest research of some flavonoids as a potential candidate for the treatment of emotional disorders. We summarize their behavioral, molecular, physiological, and neurochemical effects in various in vitro and in vivo models. Therefore, in the present work, the latest studies were collected on the most important flavonoid compounds and their underlying mechanisms of action in emotion-related disorders were discussed.

Entities:  

Keywords:  Anxiety; Depression; Emotional disorders; Flavonoids; Mechanisms of action; Therapeutic effects

Mesh:

Substances:

Year:  2020        PMID: 33225387     DOI: 10.1007/s12272-020-01292-5

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  7 in total

1.  Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method.

Authors:  Dong Yu Lim; Minyeong Pang; Jaehyeok Lee; Jihoon Lee; Ji-Hyeon Jeon; Jin-Hyang Park; Min-Koo Choi; Im-Sook Song
Journal:  Arch Pharm Res       Date:  2022-09-30       Impact factor: 6.010

2.  Persimmon leaf extract alleviates chronic social defeat stress-induced depressive-like behaviors by preventing dendritic spine loss via inhibition of serotonin reuptake in mice.

Authors:  Hui Yu; Shumin Shao; Junnan Xu; Haibiao Guo; Zhangfeng Zhong; Jiangping Xu
Journal:  Chin Med       Date:  2022-06-06       Impact factor: 4.546

3.  Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression: A Meta-Analysis and Systematic Review.

Authors:  Baofu Wang; Yu Teng; Yang Li; Sijia Lai; Yang Wu; Shiqi Chen; Tong Li; Xiaowan Han; Hufang Zhou; Yu Wang; Ziwen Lu; Haiyan Li; Yukun Ding; Liang Ma; Mingjing Zhao; Xian Wang
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

Review 4.  Does Flavonoid Consumption Improve Exercise Performance? Is It Related to Changes in the Immune System and Inflammatory Biomarkers? A Systematic Review of Clinical Studies since 2005.

Authors:  Patricia Ruiz-Iglesias; Abril Gorgori-González; Malén Massot-Cladera; Margarida Castell; Francisco J Pérez-Cano
Journal:  Nutrients       Date:  2021-03-30       Impact factor: 5.717

Review 5.  Emerging Role of Flavonoids as the Treatment of Depression.

Authors:  Arzoo Pannu; Prabodh Chander Sharma; Vijay Kumar Thakur; Ramesh K Goyal
Journal:  Biomolecules       Date:  2021-12-03

6.  Dietary Intake of Flavonoids and Carotenoids Is Associated with Anti-Depressive Symptoms: Epidemiological Study and In Silico-Mechanism Analysis.

Authors:  Seon-Joo Park; Varun Jaiswal; Hae-Jeung Lee
Journal:  Antioxidants (Basel)       Date:  2021-12-27

7.  Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.

Authors:  Lin Huang; Jiangyan Chen; Jin Quan; Debing Xiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.